Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine
- 1 January 1996
- journal article
- Published by Elsevier in The Lancet
- Vol. 347 (8996), 215-219
- https://doi.org/10.1016/s0140-6736(96)90402-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Reversible Lymphoma in the Setting of Azathioprine Therapy for Crohn's DiseaseNew England Journal of Medicine, 1994
- Long-term neoplasia risk after azathioprine treatment in inflammatory bowel diseaseThe Lancet, 1994
- Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemiaThe Lancet, 1994
- Practical problems in fitting a proportional hazards model to data with udated measurements of the covariatesStatistics in Medicine, 1994
- Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.Gut, 1993
- Long-Term Immunosuppressive Treatment in Crohn's DiseaseScandinavian Journal of Gastroenterology, 1985
- Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's diseaseDigestive Diseases and Sciences, 1981
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980
- A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITYThe Lancet, 1980
- 6-Mercaptopurine Treatment of Pregnant Mice: Effects on Second and Third GenerationsScience, 1978